Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems

Journal of Gene Medicine

Volumn 4, Issue 3, 2002, Pages 258-270

  Go, William Y ^a   Ho, Steffan N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dimerizer; Doxycycline; Rapamycin; Reverse tet; Tet repressor; Tet on; Transcriptional switch

Indexed keywords

DNA; DOXYCYCLINE; RAPAMYCIN; LIGAND; REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE ENCODING TRANSPOSON REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE-ENCODING TRANSPOSON REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING SITE; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIMERIZATION; DNA BINDING; EUKARYOTE; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN DOMAIN; REPORTER GENE; SENSITIVITY ANALYSIS; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; MOUSE; PHYSIOLOGY; WESTERN BLOTTING;

EUKARYOTA; MAMMALIA;

ANIMALS; BLOTTING, WESTERN; DIMERIZATION; GENES, REPORTER; HUMANS; LIGANDS; MICE; REPRESSOR PROTEINS; SIROLIMUS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0036579880     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.271     Document Type: Article

References (26)

1. Clackson T. Controlling mammalian gene expression with small molecules. Curr Opin Chem Biol 1997; 1: 210-218.
2. Fussenegger M. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 2001; 17: 1-51.
3. Lewandoski M. Mouse genomic technologies: conditional control of gene expression in the mouse. Nat Rev Genet 2001; 2: 743-755.
4. Chin L, Tam A, Pomerantz J, et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999; 400: 468-472.
5. Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999; 4: 199-207.
6. Kistner A, Gossen M, Zimmermann F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad Sci U S A 1996; 93: 10933-10938.
7. Malleret G, Haditsch U, Genoux D, et al. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 2001; 104: 675-686.
8. Mansuy IM, Mayford M, Jacob B, et al. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 1998; 92 39-49.
9. Magari SR, Rivera VM, Iuliucci JD, et al. Pharmacologic control of a humanized gene therapy system implanted into nude mice. J Clin Invest 1997; 100: 2865-2872.
10. Rivera VM, Ye X, Courage NL, et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci U S A 1999; 96: 8657-8662.
11. Ye X, Rivera VM, Zoltick P, et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999; 283: 88-91.
12. Ho SN, Biggar SR, Spencer DM, et al. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 1996; 382: 822-826.
13. Rivera VM, Clackson T, Natesan S, et al. A humanized system for pharmacologic control of gene expression. Nat Med 1996; 2: 1028-1032.
14. Pollock R, Issner R, Zoller K, et al. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci U S A 2000; 97: 13221-13226.
15. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
16. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
17. Takebe Y, Seiki M, Fujisawa J, et al. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988; 8: 466-472.
18. Chen J, Zheng XF, Brown EJ, et al. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad Sci U S A 1995; 92: 4947-4951.
19. Liberles SD, Diver ST, Austin DJ, et al. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci U S A 1997; 94: 7825-7830.
20. Northrop JP, Ullman KS, Crabtree GR. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 1993; 268: 2917-2923.
21. Cullen BR, Malim MH. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol 1992; 216: 362-368.
22. Rivera VM. Controlling gene expression using synthetic ligands. Methods 1998; 14(4): 421-429
23. Senner V, Sotoodeh A, Paulus W. Regulated gene expression in glioma cells: a comparison of three inducible systems. Neurochem Res 2001; 26: 521-524.
24. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 1997; 25: 2723-2729.
25. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
26. Shockett PE, Schatz DG. Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci U S A 1996; 93: 5173-5176.